250 related articles for article (PubMed ID: 19758589)
1. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation.
Seizer P; Schönberger T; Schött M; Lang MR; Langer HF; Bigalke B; Krämer BF; Borst O; Daub K; Heidenreich O; Schmidt R; Lindemann S; Herouy Y; Gawaz M; May AE
Atherosclerosis; 2010 Mar; 209(1):51-7. PubMed ID: 19758589
[TBL] [Abstract][Full Text] [Related]
2. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilin A (CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitis.
Liu L; Li C; Cai C; Xiang J; Cao Z
Biochem Biophys Res Commun; 2010 Jan; 391(1):1000-6. PubMed ID: 19968957
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis.
Seizer P; Klingel K; Sauter M; Westermann D; Ochmann C; Schönberger T; Schleicher R; Stellos K; Schmidt EM; Borst O; Bigalke B; Kandolf R; Langer H; Gawaz M; May AE
J Mol Cell Cardiol; 2012 Jul; 53(1):6-14. PubMed ID: 22446162
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes.
Yuan W; Ge H; He B
Atherosclerosis; 2010 Dec; 213(2):415-21. PubMed ID: 21035802
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin A-EMMPRIN interaction induces invasion of head and neck squamous cell carcinoma.
Takahashi M; Suzuki S; Ishikawa K
Oncol Rep; 2012 Jan; 27(1):198-203. PubMed ID: 21956400
[TBL] [Abstract][Full Text] [Related]
9. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.
Fan Y; Wang J; Wei L; He B; Wang C; Wang B
Int J Cardiol; 2011 Oct; 152(1):49-55. PubMed ID: 20674992
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.
Major TC; Liang L; Lu X; Rosebury W; Bocan TM
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1200-7. PubMed ID: 12117738
[TBL] [Abstract][Full Text] [Related]
12. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.
Daub K; Langer H; Seizer P; Stellos K; May AE; Goyal P; Bigalke B; Schönberger T; Geisler T; Siegel-Axel D; Oostendorp RA; Lindemann S; Gawaz M
FASEB J; 2006 Dec; 20(14):2559-61. PubMed ID: 17077283
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells.
Zhang J; Ge H; Wang C; Guo TB; He Q; Shao Q; Fan Y
Int J Cardiol; 2007 May; 117(3):373-80. PubMed ID: 16860414
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus.
Ramachandran S; Vinitha A; Kartha CC
Cardiovasc Diabetol; 2016 Nov; 15(1):152. PubMed ID: 27809851
[TBL] [Abstract][Full Text] [Related]
15. Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
de Oliveira Nóbrega FJ; de Oliveira DHIP; Vasconcelos RG; Nonaka CFW; Queiroz LMG
Arch Oral Biol; 2016 Dec; 72():172-178. PubMed ID: 27597537
[TBL] [Abstract][Full Text] [Related]
16. Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients.
Schmohl JU; Daub K; von Ungern-Sternberg SN; Lindemann S; Schönberger T; Geisler T; Gawaz M; Seizer P
Herz; 2015 May; 40 Suppl 3():269-76. PubMed ID: 24305990
[TBL] [Abstract][Full Text] [Related]
17. The role of extracellular matrix metalloproteinase inducer (EMMPRIN) in the regulation of bovine endometrial cell functions.
Mishra B; Kizaki K; Sato T; Ito A; Hashizume K
Biol Reprod; 2012 Jun; 87(6):149. PubMed ID: 23115270
[TBL] [Abstract][Full Text] [Related]
18. SP-8356, a Novel Inhibitor of CD147-Cyclophilin A Interactions, Reduces Plaque Progression and Stabilizes Vulnerable Plaques in apoE-Deficient Mice.
Pahk K; Joung C; Song HY; Kim S; Kim WK
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877775
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregates-induced human CD34+ progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 in vitro.
Stellos K; Seizer P; Bigalke B; Daub K; Geisler T; Gawaz M
Semin Thromb Hemost; 2010 Mar; 36(2):139-45. PubMed ID: 20414828
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) as a novel regulator of myogenic cell differentiation.
Attia M; Huet E; Delbé J; Ledoux D; Menashi S; Martelly I
J Cell Physiol; 2011 Jan; 226(1):141-9. PubMed ID: 20648565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
